News for 'Jubilant Organosys'

Expats drive Jubilant's drug discovery business

Expats drive Jubilant's drug discovery business

Rediff.com27 Nov 2006

Increasing band of expats is driving the Jubilant Organosys drug development and discovery business. Of the total 1,025 scientific manpower strength

Jubilant acquires DRAXIS for $225 mn

Jubilant acquires DRAXIS for $225 mn

Rediff.com5 Apr 2008

Leading contract drug maker Jubilant Organosys on Friday announced the acquisition of Canadian speciality drug company DRAXIS Health for $255 million (around Rs 1020 crore). The board of DRAXIS has given its unanimous approval and the transaction is expected to close in the second quarter of 2008 after the necessary shareholder and court approvals.

Jubilant buys US firm for $138m

Jubilant buys US firm for $138m

Rediff.com25 Apr 2007

Hollister, which posted an annual turnover of $55 million in 2006, has been posting 40 per cent compound annual growth rate (CAGR) over the last four years.

Forex losses dent  Biocon, Jubilant net

Forex losses dent Biocon, Jubilant net

Rediff.com29 Apr 2009

Year 2008 results of India's largest drug maker, Ranbaxy Laboratories, and Wockhardt were also impacted by forex losses. Companies such as Aurobindo and Orchid are also expected to post forex losses, say analysts.

Jubilant buys US co for $12.25 mn

Jubilant buys US co for $12.25 mn

Rediff.com1 Jul 2005

Jubilant Organosys on Friday announced the acquisition of US-based Trinity Laboratories Inc along with its wholly-owned subsidiary Trigen Laboratories Inc for $12.25 million.

Jubliant to list US firm

Jubliant to list US firm

Rediff.com6 Apr 2005

Pharma majors to invest in drug discovery

Pharma majors to invest in drug discovery

Rediff.com11 Feb 2008

Pharma majors are collaborating with foreign companies to develop newer drugs.

Big pharma cos join outsourcing queue

Big pharma cos join outsourcing queue

Rediff.com17 Aug 2009

India emerging as a big global destination for contract manufacturing, unlike R&D outsourcing.

Hari Bhartia is new CII president

Hari Bhartia is new CII president

Rediff.com12 May 2010

B Muthuraman, vice chairman, Tata Steel, has been elected as the vice president of CII.

Drug firms bet big on SEZs

Drug firms bet big on SEZs

Rediff.com12 Apr 2006

Sunil Mittal meets Hillary Clinton

Sunil Mittal meets Hillary Clinton

Rediff.com7 Jun 2007

A CII delegation, led by Confederation of Indian Industry president and Bharti Enterprises CEO Sunil Bharti Mittal, called on US Democratic presidential candidate Senator Hillary Rodham Clinton at the Capitol Hill in Washington, DC on Wednesday.

Pharma firms struggle with debt overload

Pharma firms struggle with debt overload

Rediff.com10 Apr 2009

Dr Reddy's Laboratories, Jubilant Organosys, Orchid Chemicals, Aurobindo Pharma and Shasun Chemicals and Drugs are among those who have borrowed either to expand locally or to acquire companies abroad, but are now struggling to repay the dues, analysts say. Some of the companies' debt now exceeds their market capitalisation, as local and global investors sold stocks on concerns over slowdown and falling revenues. A few drug makers may be forced to sell assets to repay debt.

India Inc to cash in on their plans

India Inc to cash in on their plans

Rediff.com25 Apr 2006

24 Indian cos in Forbes Global list

24 Indian cos in Forbes Global list

Rediff.com26 Oct 2004

Leading IT companies i-flex Software and Satyam Computers have made their way to Forbes Global's list of 100 'best under a billion' companies in Asia Pacific.

Top pharma M&A deals in 2005

Top pharma M&A deals in 2005

Rediff.com29 Dec 2005

CEOs from India, US discuss IPR, piracy issues

CEOs from India, US discuss IPR, piracy issues

Rediff.com26 Jan 2015

Issues related with intellectual property rights, including piracy of films and software, figured prominently during the India-US CEO Forum in New Delhi attended by Prime Minister Narendra Modi and US President Barack Obama.